ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,000Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 3734

$1.18M Total Retail Price of All Prescriptions

Rank: 46 out of 3734

736 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 736 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 736 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 19,695 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 1,018 936 1 10
OMEPRAZOLE 853 738 2 4
LEVOTHYROXINE SODIUM 743 676 3 2
CITALOPRAM HBR 664 523 4 16
FUROSEMIDE 659 600 5 7
AMLODIPINE BESYLATE 565 497 6 5
METOPROLOL TARTRATE 550 530 7 6
SIMVASTATIN 440 386 8 1
LISINOPRIL 425 364 9 3
PRAVASTATIN SODIUM 423 302 10 15
DONEPEZIL HCL 408 403 11 25
POLYETHYLENE GLYCOL 3350 404 384 12 53
LANTUS 316 308 13 54
IPRATROPIUM-ALBUTEROL 312 301 14 98
OXYCODONE HCL 295 243 S2 15 58
METFORMIN HCL 277 227 16 8
NAMENDA 276 276 17 44
PREDNISONE 263 231 18 42
MIRTAZAPINE 258 248 19 45
FENTANYL 257 218 S2 20 65
ATORVASTATIN CALCIUM 252 211 21 11
HYDROCODONE-ACETAMINOPHEN 239 184 S3 22 12
GABAPENTIN 228 162 23 17
NOVOLOG 227 220 24 112
CEFUROXIME 218 207 25 168
RISPERIDONE 204 181 26 62
RANITIDINE HCL 204 189 26 32
CLOPIDOGREL 203 196 28 23
METOPROLOL SUCCINATE 194 172 29 14
POTASSIUM CHLORIDE 186 173 30 19
HYDROCHLOROTHIAZIDE 185 171 31 9
ATENOLOL 181 154 32 13
PANTOPRAZOLE SODIUM 181 146 32 22
QUETIAPINE FUMARATE 180 142 34 82
DIGOXIN 175 175 35 43
SERTRALINE HCL 166 138 36 18
TRAMADOL HCL 155 145 37 20
ISOSORBIDE MONONITRATE ER 151 142 38 34
CRESTOR 142 99 39 28
ALLOPURINOL 135 131 40 33
AZITHROMYCIN 132 117 41 38
GLIPIZIDE ER 129 123 42 119
ROPINIROLE HCL 126 112 43 118
ZOLPIDEM TARTRATE 120 100 44 24
PLAVIX 117 116 45 39
KLOR-CON M20 116 108 46 48
ADVAIR DISKUS 116 89 46 35
MUPIROCIN 108 59 48 189
TRAZODONE HCL 107 93 49 49
BUPROPION HCL SR 104 66 50 165
TAMSULOSIN HCL 101 73 51 29
MELOXICAM 100 74 52 52
ZETIA 100 82 52 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 92 52 117
FAMOTIDINE 97 90 55 60
CLOTRIMAZOLE 97 95 55 418
EXELON 97 97 55 150
DIVALPROEX SODIUM 92 52 58 99
VENLAFAXINE HCL ER 91 74 59 84
NOVOLIN 70-30 89 89 60 252
SEROQUEL 89 71 60 161
OXYCODONE-ACETAMINOPHEN 86 54 S2 62 51
PHENYTOIN SODIUM EXTENDED 85 74 63 149
CARBIDOPA-LEVODOPA 85 85 63 92
AMOX TR-POTASSIUM CLAVULANATE 85 58 63 164
SINGULAIR 83 56 66 95
CELEBREX 82 56 67 69
OLANZAPINE 79 79 68 106
CARVEDILOL 79 76 68 30
CYMBALTA 78 68 70 67
LYRICA 77 60 71 124
COLESTIPOL HCL 76 60 72 334
FLUTICASONE PROPIONATE 74 47 73 46
SPIRIVA 73 59 74 40
NIASPAN 73 42 74 125
BYSTOLIC 72 66 76 148
ALBUTEROL SULFATE 70 67 77 128
METOCLOPRAMIDE HCL 70 61 77 158
PROAIR HFA 69 44 79 83
GLIPIZIDE 69 57 79 57
OXYBUTYNIN CHLORIDE ER 68 48 81 141
CEFDINIR 67 55 82 300
LOSARTAN POTASSIUM 67 64 82 21
GLIPIZIDE XL 65 56 84 85
CEPHALEXIN 64 54 85 120
DILTIAZEM 24HR CD 63 62 86 97
FINASTERIDE 63 55 86 88
VESICARE 63 63 86 157
AMITRIPTYLINE HCL 62 58 R 89 94
NASONEX 62 51 89 239
FLUOXETINE HCL 62 52 89 61
BENZTROPINE MESYLATE 61 25 R 92 173
ASMANEX 61 57 92 451
NEXIUM 60 53 94 36
DILTIAZEM 24HR ER 60 57 94 86
PRIMIDONE 60 46 94 274
CLONIDINE HCL 58 28 97 79
VENTOLIN HFA 56 33 98 70
MORPHINE SULFATE 55 55 S2 99 220
ISOSORBIDE DINITRATE 55 55 99 322
NITROFURANTOIN MONO-MACRO 54 53 101 196
PEN NEEDLE 54 33 101 152
ENDOCET 53 41 S2 103 89
MONTELUKAST SODIUM 53 33 103 175
OXYCONTIN 52 42 S2 105 121
LANSOPRAZOLE 52 48 105 155
LEVETIRACETAM 51 33 107 105
HALOPERIDOL 51 25 107 212
DIOVAN 50 50 109 31
SYMBICORT 50 40 109 186
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.